Unknown primary carcinoma: Randomised studies are needed to identify optimal treatments and their benefits
- 1 December 1996
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (13) , 2256-2261
- https://doi.org/10.1016/s0959-8049(96)00264-x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Evaluation of six tumor markers in patients with carcinoma of unknown primaryMedical and Pediatric Oncology, 1994
- Treatment of Patients with Cancer of an Unknown Primary SiteNew England Journal of Medicine, 1993
- Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience.Journal of Clinical Oncology, 1992
- Peritoneal Carcinomatosis of Unknown Primary Site in WomenAnnals of Internal Medicine, 1989
- Poorly Differentiated Neuroendocrine Carcinoma of Unknown Primary SiteAnnals of Internal Medicine, 1988
- Metastatic adenocarcinoma of unknown primary site. A randomized study of two combination chemotherapy regimensEuropean Journal of Cancer and Clinical Oncology, 1987
- Prognostic factors in metastatic carcinoma of unknown primary.Journal of Clinical Oncology, 1986
- Reporting results of cancer treatmentCancer, 1981
- Unknown primary adenocarcinoma: incidence of overinvestigation and natural history.BMJ, 1979
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958